Company Filing History:
Years Active: 2015-2016
Title: Janet R. Sparrow: Innovator in Ophthalmology
Introduction
Janet R. Sparrow is a prominent inventor based in New York, NY (US), known for her significant contributions to the field of ophthalmology. With a focus on age-related macular degeneration and Stargardt disease, she has developed innovative methods that aim to improve the treatment of these conditions. Janet holds 2 patents, showcasing her dedication to advancing medical science.
Latest Patents
Janet R. Sparrow's latest patents include groundbreaking work on non-retinoid antagonists for the treatment of age-related macular degeneration and Stargardt disease. One of her patents describes a method for treating diseases characterized by excessive lipofuscin accumulation in the retina of mammals. This method involves administering an effective amount of a non-retinoid antagonist compound or a pharmaceutically acceptable salt thereof. Another patent focuses on a non-retinoid RBP4 antagonist for treating bisretinoid-mediated macular degeneration, detailing a method that includes administering a compound with a specific structure or its ester or pharmaceutically acceptable salt.
Career Highlights
Janet R. Sparrow is affiliated with Columbia University, where she continues her research and development in ophthalmology. Her work has garnered attention for its potential to transform treatment options for patients suffering from retinal diseases.
Collaborations
Some of her notable coworkers include Konstantin Petrukhin and Rando L. Allikmets, who contribute to her research efforts and collaborative projects.
Conclusion
Janet R. Sparrow's innovative work in the field of ophthalmology highlights her commitment to improving patient outcomes through her patented inventions. Her contributions are paving the way for new treatment methodologies in the fight against age-related macular degeneration and Stargardt disease.